HighMark Wealth Management LLC Purchases 163,500 Shares of Health Catalyst, Inc. $HCAT

Key Points

• HighMark Wealth Management LLC significantly increased its stake in Health Catalyst, acquiring 163,500 shares, bringing its total holdings to 164,750 shares valued at approximately $621,000.
• During Q1, several large investors growth in Health Catalyst, with 85.00% of the stock currently held by institutional investors.
• Analyst ratings for Health Catalyst include a consensus rating of "Hold" with a price target averaging around $4.73, with some analysts downgrading their targets significantly.

HighMark Wealth Management LLC grew its position in Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) by 13,080.0% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 164,750 shares of the company's stock after acquiring an additional 163,500 shares during the period. HighMark Wealth Management LLC owned 0.24% of Health Catalyst worth $621,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. First Light Asset Management LLC raised its position in Health Catalyst by 99.1% in the 1st quarter. First Light Asset Management LLC now owns 10,436,807 shares of the company's stock valued at $47,279,000 after purchasing an additional 5,195,686 shares during the last quarter. Nepsis Inc. raised its holdings in shares of Health Catalyst by 2,072.1% in the first quarter. Nepsis Inc. now owns 2,090,812 shares of the company's stock valued at $9,471,000 after buying an additional 1,994,555 shares during the last quarter. Whetstone Capital Advisors LLC acquired a new position in Health Catalyst during the 1st quarter worth about $7,724,000. Nuveen LLC acquired a new position in Health Catalyst during the 1st quarter worth about $2,674,000. Finally, Connor Clark & Lunn Investment Management Ltd. grew its holdings in Health Catalyst by 172.6% during the 1st quarter. Connor Clark & Lunn Investment Management Ltd. now owns 694,361 shares of the company's stock worth $3,145,000 after acquiring an additional 439,599 shares during the last quarter. 85.00% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

HCAT has been the subject of a number of research analyst reports. Evercore ISI boosted their target price on shares of Health Catalyst from $3.00 to $4.00 and gave the stock an "in-line" rating in a research note on Thursday, August 28th. Cantor Fitzgerald reissued a "neutral" rating and issued a $4.00 price target (down previously from $9.00) on shares of Health Catalyst in a report on Friday, August 8th. BTIG Research restated a "neutral" rating on shares of Health Catalyst in a research report on Friday, September 5th. Citigroup downgraded Health Catalyst from a "buy" rating to a "neutral" rating and reduced their price objective for the stock from $6.50 to $3.50 in a report on Friday, August 8th. Finally, Canaccord Genuity Group lowered their target price on Health Catalyst from $9.00 to $5.00 and set a "buy" rating for the company in a research note on Friday, August 29th. Three investment analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company's stock. According to MarketBeat.com, Health Catalyst has a consensus rating of "Hold" and a consensus price target of $4.73.

Health Catalyst Price Performance

Shares of HCAT stock opened at $2.80 on Friday. The firm's 50 day moving average price is $3.23 and its two-hundred day moving average price is $3.72. The stock has a market cap of $197.04 million, a PE ratio of -1.85 and a beta of 1.62. Health Catalyst, Inc. has a 52-week low of $2.52 and a 52-week high of $9.24. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.83 and a current ratio of 1.83.

About Health Catalyst

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.